The present study demonstrated that lncRNA MEG3 could become involved in lipid synthesis by regulating the expression and translocation to the nucleus of FOXO1, providing new insights into the molecular mechanism and control of NAFLD. The gene discussed is MEG3; the disease is metabolic dysfunction-associated steatotic liver disease.